Health
US
North America
Psychemedics
$14.569876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.68 (-4.46%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Psychemedics and other stocks, options, ETFs, and crypto commission-free!
About
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. Read More It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
Employees
250
Headquarters
Acton, Massachusetts
Founded
1986
Market Cap
83.93M
Price-Earnings Ratio
17.54
Dividend Yield
4.35
Average Volume
14.98K
High Today
$15.35
Low Today
$14.56
Open Price
$15.22
Volume
8.73K
52 Week High
$22.31
52 Week Low
$13.94
Collections
Health
US
North America
News
Simply Wall StMar 20
Some Psychemedics (NASDAQ:PMD) Shareholders Are Down 25%
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market – but in the process, they risk under-performance. For example, the Psychemedics Corporation (NASDAQ:PMD) share price is down 25% in the last year. That’s well bellow the market return of 5.0%. The silver lining (for longer term investors) is that the stock is still 10% higher than it was three years ago. Even worse, it’s down 21% in about a month, which isn’t fun...
Yahoo FinanceMar 18
Those Who Purchased Psychemedics (NASDAQ:PMD) Shares A Year Ago Have A 26% Loss To Show For It
Investors can approximate the average market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. That downside risk was realized by Psychemedics Corporation (NASDAQ:PMD) shareholders over the last year, as the share price declined 26%. That falls noticeably short of the market return of around 3.9%. Longer term investors have fared much better, since the share price is up 4.1% in three years. Even worse, it’s down 22% in about a mont...
Simply Wall StMar 8
Psychemedics Corporation (NASDAQ:PMD): 4 Days To Buy Before The Ex-Dividend Date
Important news for shareholders and potential investors in Psychemedics Corporation (NASDAQ:PMD): The dividend payment of US$0.18 per share will be distributed to shareholders on 25 March 2019, and the stock will begin trading ex-dividend at an earlier date, 13 March 2019. Should you diversify into Psychemedics and boost your portfolio income stream?
Price Paid on Robinhood
21% Lower
Right Now
52 Week Low
$13.94
Average Price Paid
$18.32
52 Week High
$22.31
Earnings
$0.00
$0.08
$0.17
$0.25
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected Apr 23, After Hours